Ersilia Tolino
Latina, 04100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 96 publications
Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area.
Journal: Dermatology and therapy
Published: March 11, 2026
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study.
Journal: Dermatology and therapy
Published: August 12, 2025
Elective First-Line Use of Dimethyl Fumarate in Psoriasis: Insights from an Italian Cohort.
Journal: Dermatology practical & conceptual
Published: June 25, 2025
Use of upadacitinib in the treatment of moderate to severe atopic dermatitis: patient profiling, dose selection, and therapy modulation, what does real-life teach us?
Journal: The Journal of dermatological treatment
Published: June 09, 2025
Letter: Effectiveness and Safety of Tralokinumab for the Elderly with Atopic Dermatitis in a Real-World Setting-IL AD.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: June 05, 2025
Safety and Effectiveness Profile of Dupilumab in the Treatment of Atopic Dermatitis in Special Populations.
Journal: Acta dermato-venereologica
Published: April 22, 2025
Safety and Effectiveness Profile of Dupilumab in the Treatment of Atopic Dermatitis in Special Populations.
Journal: Acta dermato-venereologica
Published: April 22, 2025
Evaluating the Efficacy of Bimekizumab across the Different Sensitive Areas in Moderate-to-Severe Psoriasis: A 52-week Italian Multicenter Real-Life Lazio Experience.
Journal: Dermatology practical & conceptual
Published: January 14, 2025
Five-year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real-world study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: December 05, 2024
Last Updated: 09/26/2026